CXCL8 and breast cancer: As another mechanism to support CTCs survival, platelets secrete lysophophatidic acid (LPA) that binds to its receptors, LPAR1, 2 and (3) on breast cancer cells and activates the secretion of IL6, IL8, CCL2 and CXCL1, enhance survival and increases the migration potential of CTCs (131).